Jefferies Financial Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,100
Closed -$162K – 1646
2026
Q2
$162K Buy
+11,100
New +$107K ﹤0.01% 1497
2024
Q4
– Sell
-25,001
Closed -$369K – 1747
2024
Q3
$369K Buy
+25,001
New +$391K ﹤0.01% 1064
2024
Q1
– Sell
-15,423
Closed -$250K – 1883
2023
Q4
$250K Buy
+15,423
New +$252K ﹤0.01% 1426

Other funds holding NEO

Jefferies Financial Group's NEO Position: Q3 2026 in Review

Jefferies Financial Group sold out of NeoGenomics (NEO) in Q3 2026, closing a stake of 11,100 shares — an estimated $162K sold.

Jefferies Financial Group first reported a position in NEO in Q4 2023 and held it in 3 quarters. The position peaked at $369K in Q3 2024. 297 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Jefferies Financial Group reported no remaining NeoGenomics position as of Q3 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 11,100 NeoGenomics shares in Q3 2026, an estimated $162K.
  • Jefferies Financial Group first reported a position in NeoGenomics in Q4 2023 and held it in 3 quarters.
  • Jefferies Financial Group's NeoGenomics position peaked at $369K in Q3 2024.
  • 297 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.